Kenvue Inc. (FRA:J4D)

Market Cap	26.55B
Revenue (ttm)	12.92B
Net Income (ttm)	1.21B
Shares Out	n/a
EPS (ttm)	0.63
PE Ratio	21.93
Forward PE	15.11
Dividend	0.75 (5.43%)
Ex-Dividend Date	Aug 13, 2025

Volume	n/a
Average Volume	315
Open	13.92
Previous Close	13.85
Day's Range	13.90 - 14.04
52-Week Range	13.64 - 23.50
Beta	n/a
RSI	23.20
Earnings Date	Nov 7, 2025

About Kenvue

Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other...

• Industry: Soap, Detergents, And Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2022
• Employees: 22,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: J4D

Financial Performance

In 2024, Kenvue's revenue was $15.46 billion, an increase of 0.07% compared to the previous year's $15.44 billion. Earnings were $1.03 billion, a decrease of -38.10%.

Financial numbers in USD